{"References": [{"title": "Natural killer cells and T cells in cancer immunotherapy: partners or competitors?", "authors": "Michael A. Caligiuri", "journal": "Nature Reviews Immunology", "year": "2008", "volumes": "8", "first page": "645", "last page": "653", "DOI": "10.1038/nri2358"}, {"title": "Harnessing the immune system for cancer therapy", "authors": "James P. Allison, Padmanee Sharma, Michael B. Atkins", "journal": "Nature Reviews Cancer", "year": "2018", "volumes": "18", "first page": "168", "last page": "182", "DOI": "10.1038/nrc.2017.109"}, {"title": "Combination cancer immunotherapy and new immunomodulatory targets", "authors": "Drew M. Pardoll", "journal": "Nature Reviews Drug Discovery", "year": "2015", "volumes": "14", "first page": "561", "last page": "584", "DOI": "10.1038/nrd4591"}, {"title": "The role of natural killer cells in cancer immunotherapy", "authors": "Eric Vivier, David H. Raulet, Alessandro Moretta, Michael A. Caligiuri, Laurence Zitvogel, Lloyd J. Old, Wayne M. Yokoyama, Sophie Ugolini", "journal": "Nature Reviews Immunology", "year": "2011", "volumes": "11", "first page": "239", "last page": "252", "DOI": "10.1038/nri2937"}, {"title": "T cell and NK cell therapy for cancer", "authors": "Carl H. June, Michel Sadelain", "journal": "Science", "year": "2018", "volumes": "359", "first page": "1361", "last page": "1365", "DOI": "10.1126/science.aar6711"}, {"title": "Engineering strategies to overcome the current roadblocks in CAR T cell therapy", "authors": "Marcela V. Maus, Carl H. June", "journal": "Nature Reviews Clinical Oncology", "year": "2016", "volumes": "13", "first page": "370", "last page": "383", "DOI": "10.1038/nrclinonc.2016.36"}, {"title": "Natural killer cells in cancer immunotherapy", "authors": "Jeffrey S. Miller", "journal": "Nature Biotechnology", "year": "2013", "volumes": "31", "first page": "575", "last page": "582", "DOI": "10.1038/nbt.2578"}, {"title": "The future of immune checkpoint therapy", "authors": "James P. Allison, Antoni Ribas", "journal": "Science", "year": "2015", "volumes": "348", "first page": "56", "last page": "61", "DOI": "10.1126/science.aaa8172"}, {"title": "Adoptive cell transfer as personalized immunotherapy for human cancer", "authors": "Steven A. Rosenberg, Nicholas P. Restifo", "journal": "Science", "year": "2015", "volumes": "348", "first page": "62", "last page": "68", "DOI": "10.1126/science.aaa4967"}, {"title": "Cancer immunotherapy using checkpoint blockade", "authors": "Suzanne L. Topalian, Charles G. Drake, Drew M. Pardoll", "journal": "Science", "year": "2018", "volumes": "359", "first page": "1350", "last page": "1355", "DOI": "10.1126/science.aar4060"}]}